Bone Morphogenetic Proteins 7 market is expected to reach USD 1,711.8 million by 2029 from USD 564.5 million in 2018, at a CAGR of 16.9%. The growth of the market is mainly attributed to the increasing incidence of bone diseases, rising demand for minimally invasive surgeries, and technological advancements in bone graft substitute products. Bone […]
